In order to evaluate the susceptibility and resistance pattern of bacteria and fungal isolates obtained from herbal medicine products (HMPs) marketed in Nigeria to conventional antibiotics, a total of seventy-five (75) bacteria and fifty-two (52) fungi isolated from the HMPs were screened for susceptibility to conventional antibiotics using the disc diffusion method. Most of the bacteria isolates were sensitive to the fluoroquinolones (ciprofloxacin, 85.3%, norfloxacin 93.3%) and the aminoglycosides (streptomycin 90%, gentamycin 89.3%).
INTRODUCTION
Herbal Medicine products (HMPs) are becoming increasingly popular (Fisher and Ward, 1994; Brevoort, 1998; Eisenberg et al., 1998 ). An estimated 80% of the world's population still depends on traditional herbal medicines for their health security (Carter, 2001) . In most African countries including Nigeria, herbal medicine is recognized as an important component of health care system, especially among rural dwellers that constitute about 70% of the population (Esimone et al., 2002) . Also, the ever increasing cost of orthodox health care services coupled with the side effects of certain synthetic drug therapies, has further caused a large proportion of pa-*Corresponding author. E-mail: coesimone@yahoo.com tients in the developing countries to resort to alternative herbal health care which they feel is natural, safer, more accessible, more economical and takes into consideration the people's socio-cultural values (Nwaogu, 1997; Carter, 2001) .
Although the World Health Organisation (WHO) has advocated for the integration of HMP into the primary health care system of developing countries (WHO, 1978 (WHO, , 1989 , safety issues related to herbal drugs continue to be ignored by the herbalist whose methods of concocting herbal preparations for the public are usually unhygienic with the attendant microbiological hazards (Tella, 1977) . Accordingly, gross microbial contamination of herbal medicinal products commonly consumed in Nigeria has been severally demonstrated (Onawunmi and Lamikanra, 1987; Lamikanra et al., 1992; Esimone et al., 2002; Esimone et al., 2003) On the one hand, such grossly contaminated HMPs may serve as potential sources of transmission of pathogenic spoilage organisms from product to consumers (Grigo, 1976; Mendie et al., 1993) . On the other hand, presence of antibiotic resistant microbial isolates in the HMPs could lead to transfer of antibiotic resistance traits to hitherto sensitive gut or oral microflora of consumers. The present study attempts to evaluate the potential health hazards associated with the consumption of herbal medicinal products vis-a-vis the susceptibility-resistance profile of microorganisms isolated from such products.
MATERIALS AND METHODS

Herbal samples
A total of twenty-six herbal samples were used in this study. Sixteen (16) of these samples were in solid dosage forms, while nine (9) were liquid and one (1) leaf herbal tea. They were purchased at random from different herbalists in Edo State, Nigeria.
Isolation and identification of microbial contaminants in the herbal preparations
A loopful of each of the liquid sample was streaked on nutrient agar, cetrimide agar, mannitol salt agar, MacConkey agar, Kligler iron agar and Sabouraud dextrose agar. Isolated organisms were identified by their morphological, physiological and biochemical characteristics (Cowan and Steel, 1974; Leanor and Carey, 1978) . Solid samples were first agitated in sterile distilled water before streaking loopfuls into the culture media above.
Antibiotic susceptibility testing
Susceptibility tests were performed following the M2-A6 disc diffusion method recommended by the National Committee for Clinical Laboratory Standards (NCCLS, 1997) using nutrient agar and Sabouraud dextrose agar. The bacteria strains were tested against the following discs: nitrofurantoin (N), 100 µg; cefuroxime (CF), 20 µg; norbactin [norfloxacin] (NB), 10 µg; cotrimoxazole (CO), 50 µg; gentamycine (GN), 10 µg; tetracycline (TE), 50 µg; ciprofloxacin (CIP), 5 µg; nalidixic acid (NA), 30 µg; chloramphenicol (C), 10 µg; and ampicllin (AM), 25 µg (polytes Tables 2 and 3 show the antibiogram summary of all the strains isolated. The bacterial isolates were very sensitive to the fluoroquinolones (ciprofloxacin, norfloxacin) and aminoglycosides (streptomycin, gentamycin). Also susceptibility was recorded against tetracycline, septrin and erythromycin.
It is observed that Bacillus strains had 86.1% resistance to claforan, 80.6% resistance to tarivid (a brand of ofloxacin) and 8.3% resistance to gentamycin. Bacillus subtilis presented the highest number of strains resistant to all penicillins, cephalosporins and septrin (a brand of cotrimoxazole). Staphylococcus spp. demonstrated a high percentage of resistance to ampicillin (54.6%), augmentin ® (81.8%), cloxacillin (90.9%), ceporex (90.9%) and erythromycin (72.7%). All the gram-negative rod strains were resistant to -lactam antibiotics and nitrofurantoin. All Pseudomonas aeruginosa strains were resistant to chloramphenicol. Escherichia coli strains were resistant to cotrimoxazole, nalidixic acid, nitrofurantoin and ampicillin. The fungi isolates were very sensitive to tioconazole (100%) and ketoconazole (98.1%), while the least susceptibility was shown towards griseofulvin (32.7%). Susceptibility was also recorded against miconazole (88.5%), clotrimazole (78.9%) and nystatin (73.1%). The results of the inhibition zone diameters (IZD) of the antibiotics against 50, 90 and 95% range of the organisms (IZD 50 , IZD 90 and IZD 95 respectively) is presented in Table 4 .
DISCUSSION
The contaminants isolated from these herbal preparations showed wide resistance to penicillins, especially ampicillin, augmentin ® (amoxycillin-clavulanic acid combination) and cloxacillin, suggesting that they could be producers of penicillinases. Similar resistance to cephalosporins especially cefuroxamine and rocephine ® (ceftriaxone) was also observed. More worrisome is the resistance to trimethoprim-sulphamethoxazole (cotrimoxazole) observed especially against the gram negative isolates. Bacillus spp. were the most frequently found in these medicaments because they are widely distributed in the soil, dust and air because they are resistant to 0  14  17  13  16  0  14  15  14  14  12d  0  0  0  0  0  18  22  0  19  0  13b  0  17  22  20  22  20  25  14  17  14  13c  0  0  31  0  15  0  23  0  29  24  14a  0  0  0  18  22  21  18  0  15  28  14b  0  0  20  21  0  16  0  0  0  16  14c  0  19  12  23  18  17  0  0  0  20  15a  0  0  20  22  20  20  21  0  0  25  16a  0  0  0  0  0  20  15  0  0  0  16b  0  0  22  21  18  17  14  18  0  26  17a  0  0  21  18  12  20  20  15  0  16  17b  0  0  27  0  23  26  26  0  22  24  18  0  0  21  16  0  19  18  17  0  20  19a  0  0  0  21  0  16  22  0  16  18  20a  0  0  0  0  0  16  23  0  0  0  20c  0  0  0  0  0  14  19  0  28  23  20d  0  0  0  0  0  23  18  0  25  23  21b  0  14  28  16  15  23  21  0  20  20  21c  0  0  0  0  13  19  18  0  0  23  22a  0  0  0  16  0  17  12  0  0  16  23b  0  0  0  0  0  16  31  0  20  33  23c  0  0  0  0  0  16  31  0  20  33  24b  0  0  0  0  0  18  19  0  0  18  25a  0  0  0  0  0  16  13  0  0  0  25b  0  0  0  0  0  0  20  0  18  15  26a  0  18  22  12  12  14  22  12  20  18  26d  0  15  27  15  20  23  25  0  0  21  26e  0  15  30  20  19  14  20  0  17  21 Gentamycin (GN), augmentin (AG), cloxacillin (CXL), septrin (SXT), chloramphenicol (CRO), erythromycin (E), penicillin G (PN), streptomycin (S), claforan (CTX), and ciproxin (CPX). Source of disk: Jireh ® Laboratories (Nig.) lot no. 9903. environmental destructive factors (Devleeschouwer and Dony, 1979; Garcia-Arribas et al., 1986) . A number of reports have described serious human infections caused by members of the genus Bacillus even though they have been regarded as non-pathogenic (Cotton et al., 1987; Sliman et al., 1987; Kramer and Gilbert, 1989) . The Staphylococcus strains showed wide resistance to penicillins suggesting possibly that they are producers of penicillinases. Resistance to trimethoprim by S. aureus and S. epidermidis has been reported with increasing fre- 0  18  0  22  19  27  0  0  0  7c  0  0  30  0  25  20  30  0  0  0  7f  0  0  20  0  0  17  28  0  13  0  9a  0  0  0  0  23  20  19  23  0  0  9b  0  0  22  40  12  19  24  0  12  0  10b  0  0  26  0  28  20  23  0  0  0  11c  0  0  18  0  18  20  0  0  12  0  12e  0  0  11  0  18  23  26  0  0  0  13d  0  0  19  0  21  0  0  7  18  0  19b  0  0  32  0  26  20  28  0  0  0  21a  0  0  14  0  17  14  28  0  0  0  22b  0  0  24  0  18  9  0  0  0  0  23a  0  0  24  0  11  10  30  0  0  0  26c  0  0  17  0  24  20  25  0  0  0 Table 3. Contd.   25a  18  19  21  19  15  -26a  29  25  12  22  21  22 Nystatin (N), clotrimazole (C), griseofulvin (G), ketoconazole (K), tioconazole (T, and miconazole (M). quency (Archer et al., 1986; Davies and Stone, 1986) . It seems probable that S. epidermidis serves as a reservoir for resistance, which can be transferred to S. aureus. Also, intergeneric transfer of resistance among different genera of gram-positive cocci and between Bacillus species and Staphylococci and Streptococci has been reported on several occasions (Schaberg and Zerros, 1986) . Studies of clinical strains of S. aureus have often reported multi-resistance. In this study, however, medicament strains were susceptible to some antimicrobial agents. Similar results have also been reported (Devleeschouwer and Dony, 1979) . S. aureus can originate from handlers, as its habitat is human skin. Micrococcus roseus and M. luteus have also been found in liquid and solid drugs (Willense-Collinet et al., 1981; Garcia-Arribas et al., 1983) . The number of strains of Streptococci found was very few. These results are in agreement with other authors that found a similar number of these bacteria in different Pharmaceuticals (Devleeschouwer and Dony, 1979; Garcia-Arribas et al., 1983) . These gram-positive cocci are found mainly in raw materials, air and water and on human beings and like Bacillus spp., they can survive in the environment and thus contaminate the medicaments. The high level of resistance to many antimicrobial agents shown by gram negative rods is well known. Serratia and Proteus spp. are of increasing importance, as resistance to newer -lactams may be acquired by mutation in addition to plasmids (O'Brien and Acar, 1987) . Acinetobacter spp. are also known to be very resistant to aminoglycosides (Devleeschouwer et al., 1980) . This is most often due to the presence of plasmidmediated modifying enzymes. All the strains of Pseudomonas isolated were resistant to -lactam antibiotics. Inducible -lactam activity is a general property of Pseudomonas cepacia (Prince et al., 1988) . Resistance to chloramphenicol was similar to those of clinical strains in the study of Burns et al. (1989) .
The number of bacterial and fungal strains capable of causing infections is increasing, and many of them are resistant to one or more of the antimicrobial agents used in therapy. This problem has snowballed to a serious public health concern with economic, social and political implications that are global in scope, and across all environmental and ethnic boundaries. The acquisition of resistance may be due to chromosomal mutations or plasmids that are often capable of transfer from one strain of organism to another, even across the species barrier. Furthermore, the resistance genes are found on mobilizable genetic elements called transposons (O'Brien and Acar, 1987) . The ability of transposons to integrate into either conjugative plasmids or the organisms' chromosome enhances the transferability of a given resistant determinant. This process is a natural, unstoppable phenomenon exacerbated by the abuse, overuse and misuse of antimicrobials in the treatment of human illness and in animal husbandry, aquaculture and agriculture (O'Brien and Acar, 1987; Lexchin, 2000; Stohr, 2000) . The importance of surveying resistant environmental strains is that under favourable situations, they may transfer their resistance plasmids to pathogens. The problem is especially serious in hospitals where the environment can be a factor in the selection of multiresistant strains (O'Brien and Acar, 1987, Prince et al., 1988; Bryan, 1989; Burns et al., 1989) . If such organisms are present in medicaments, they could behave as opportunist pathogens and initiate an infection, particularly in immuno-compromised patients. Our challenge is to slow the rate at which resistance develops and spreads.
The high rate of resistance to antimicrobial agents of strains isolated from these herbal preparations may indicate a widespread antibiotic resistance among microorganisms from different sources. It is therefore mandatory that herbal medicines should not be taken indiscriminately and that current good manufacturing practices (cGMPs) must be observed by these herbal practitioners in the production of the medicines.
